Related Macular Degeneration Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Related Macular Degeneration stocks.

Related Macular Degeneration Stocks Recent News

Date Stock Title
Mar 28 KOD Kodiak Sciences GAAP EPS of -$1.13 misses by $0.31
Mar 28 RGNX REGENXBIO Sees Positive Results For Macular Degeneration Therapy
Mar 28 REGN Biotech Stock Roundup: PRAX, VKTX Up on Study Results & MRNA, REGN Give Updates
Mar 28 KOD Kodiak Sciences Inc (KOD) Posts Q4 and Full Year 2023 Financial Results
Mar 28 REGN Stock-Split Watch: Are These 2 Top Growth Stocks Next?
Mar 28 RGNX REGENXBIO Announces Lancet Publication of Phase I/IIa Study Evaluating ABBV-RGX-314 as a One-Time Gene Therapy for Wet AMD
Mar 28 KOD Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
Mar 28 KOD Earnings Scheduled For March 28, 2024
Mar 28 REGN Biotech veteran Art Krieg postpones retirement to build an unorthodox drug startup
Mar 27 RGNX REGENXBIO to Participate in Cantor Fitzgerald's Virtual DMD and Other Dystrophy Days
Mar 27 KOD Preview: Kodiak Sciences's Earnings
Mar 26 REGN Regeneron's Triple Threat: Eylea, Libtayo, And Dupixent Dominate
Mar 26 REGN Regeneron's (REGN) Lymphoma Candidate Rejected by the FDA
Mar 26 REGN Is Regeneron Pharmaceuticals (NASDAQ:REGN) A Risky Investment?
Mar 26 KOD Kodiak Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results and Host Business Updates Webcast on March 28, 2024
Mar 25 REGN FDA declines to approve Regeneron lymphoma drug odronextamab
Mar 25 REGN FDA rejects Regeneron lymphoma drug, setting back company’s oncology push
Mar 25 REGN UPDATE 3-Regeneron's blood cancer therapy faces setback as FDA raises trial concerns
Mar 25 REGN Regeneron Provides Update on Biologics License Application for Odronextamab
Mar 24 BNTC 11 Best ASX Stocks To Buy Now
Related Macular Degeneration

Browse All Tags